We are live on
!
Find out more
SELLAS Life Sciences
45 hedge funds and large institutions have $15.5M invested in SELLAS Life Sciences in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
8,228% more call options, than puts
Call options by funds: $3.33M | Put options by funds: $40K
500% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 3
350% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 4
139% more capital invested
Capital invested by funds: $6.47M → $15.5M (+$8.99M)
45% more funds holding
Funds holding: 31 → 45 (+14)
6.92% more ownership
Funds ownership: 8.84% → 15.75% (+6.9%)
Holders
45
Holders Change
+14
Holders Change %
+45.16%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
18
Reduced
3
Closed
4
Calls
$3.33M
Puts
$40K
Net Calls
+$3.29M
Net Calls Change
-$1.24M
Top Buyers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$7.58M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$818K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$649K |
| 4 |
BlackRock
New York
|
+$112K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$103K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$161K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$77.9K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$55.6K |
| 4 |
Goldman Sachs
New York
|
-$16.3K |
| 5 |
RS
R Squared
Central,
Hong Kong
|
-$2.29K |
